Contact UsHome

INVESTORS
News Releases
Events & Presentations
Board & Management Biographies
Corporate Governance
Financial Information
Stock Information
FAQs
Contact Us

 

 

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put OncoGenex Pharmaceuticals, Inc.'s financial performance into perspective.

Headquartered near Seattle, Washington, with an office in Vancouver, BC, OncoGenex Pharmaceuticals, Inc. is focused on the development of new therapies that address unmet needs in the treatment of cancer.

Investor Relations Contact
Susan W. Specht, Director, Investor Relations
425-686-1535
sspecht@oncogenex.com

Recent Releases


Events & Presentations

Feb 2, 2012 at 6:35 PM PT
ASCO 2012 Genitourinary Cancers Symposium Presentation

View all events & presentations »

 

 
  • Stock Information
Ticker: OGXI
Exchange: NASDAQ
Last Price: 14.02
Change: up 0.29
Volume: 46,500
4:00 PM ET - Jan 27, 2012



[ DISCLAIMER ] [ PRIVACY STATEMENT ]
© 2004-2012 Oncogenex Pharmaceuticals, Inc. All rights reserved.
Last Update: